There were 606 press releases posted in the last 24 hours and 150,119 in the last 365 days.

Global Lyme Diagnostics Welcomes Dr. Bernarda Zenker to Scientific Advisory Board

Dr. Bernarda Zenker

Groundbreaking Lyme Screen company adds experienced expert to advisory board.

RESEARCH TRIANGLE PARK, NORTH CAROLINA, UNITED STATES, January 8, 2019 /EINPresswire.com/ -- Global Lyme Diagnostics (GLD) is excited to announce that Dr. Bernarda Zenker has joined GLD’s Scientific Advisory Board.

"As a clinician, I am passionate about giving hope to individuals who have struggled and suffered. Many of my patients now have a confirmed diagnosis which had previously evaded traditional Western Blot evaluations, through testing with Global Lyme Diagnostics. I am thrilled with Global Lyme Diagnostics’ sensitive and cost-efficient testing for Lyme, Borrelia and Lyme-Coinfection testing, which has enabled hopeful and targeted treatment for my patients" says Zenker.

Global Lyme Diagnostics’ sole mission is to service the dire, unmet needs of the global Lyme community with a new diagnostic solution specific to Lyme Disease that is grounded in science and designed to significantly decrease the number of patients being misdiagnosed.

Dr. Zenker is a Board-Certified Family Physician through the American Academy of Family Medicine and is also Board-Certified in Integrative Medicine. Dr. Zenker has a particular concern for finding solutions to chronic health problems. She utilizes traditional medicine assisted with nutritional supplements and diet recommendations in the treatment and prevention of chronic diseases such as Lyme.

Through her 20 years of family practice experience, Dr. Zenker has become a trusted advisor to physicians across the country and has given hundreds of consultations on various medical matters including diagnosing and treating Lyme disease.

“We are very excited to have Dr. Zenker join our Scientific Advisory Board. Her clinical advice will be extremely valuable in furthering GLD’s science to help the global Lyme community,” stated Mickey Ramchandani, CEO of GLD. “Misdiagnosis is a core issue, as Lyme Disease can masquerade as many things – juvenile arthritis, fibromyalgia, chronic fatigue syndrome, multiple sclerosis and a host of other diseases. We are passionate about providing a diagnostic solution that decreases the misdiagnosis of Lyme Disease.”

Please contact Dustin Starnes at (919) 341-1271 or info@glymedx.com with media questions.

About Global Lyme Diagnostics
After years of research, Global Lyme Diagnostics has launched the GLD test, specific to Lyme Disease, which can be requested by clinicians at physician kit request. Patients that would like to request a kit to take to their clinicians can do so HERE. Note: The GLD Test is not yet available for PA or NY residents. More information about GLD, including the science behind the new test and the GLD team is available at the website at https://glymedx.com.

Dustin Starnes
Global Lyme Diagnostics
+1 919-341-1271
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.